I doubt that. Erasing stigma is an important step in researching these drugs. Reclassification so that they are accessable for research is another. However, proper regulation is required so that you know what you're getting and in the right dosage. The incoming administration want more deregulation. That will mean that quality of supply will be less reliable.

We are still dealing with increaing outbreaks of foodborne illness because of deregulation from the last Trump government. And this affects more than just Americans. I'm in Canada, but because we import food from the US, we are also exposed to these illnesses. My immunocompromised sister had a bout of listeria from food that she should have been able to trust. (I can't remember which food at the moment). I still have granola bars in my home that I haven't disposed of yet which were part of a separate recall.

Proper regulation works quietly for the average person. When it's working correctly, you don't notice the myriad of ways that you're kept safe every day. It's when it fails that we notice.

I'm not even talking about the fun drugs, but things like a bottle of vitamin supplements, over the counter, or prescription medication. Sure, you can test a batch, but will that mean testing one pill out of each bottle? Or could consistency drop enough that one pill might not say much about the others in the bottle?

Will testing resources get stretched to the point where many won't be able to afford them if we'll need to test each bottle of pills we buy to make sure the producer didn't just stick a nice label on lead pills to make a quick buck and disappear in the night before the fallout?